In addition, the availability of phototherapy in neonatal jaundice and several effective drug classes for the prevention and treatment of COPD, T2DM, and RS following PCI do not allow for the consideration of HO-1 modulation as an unmet medical need. The gene discussed is HMOX1; the disease is type 2 diabetes mellitus.